Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 4Phase 3 3Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 3Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 3856Neoplasms 2988Prostatic Neoplasms 1751Colorectal Neoplasms 1426Lung Neoplasms 1328Motor Activity 802Head and Neck Neoplasms 683Pancreatic Neoplasms 663Colonic Neoplasms 655Uterine Cervical Neoplasms 648Carcinoma, Non-Small-Cell Lung 629Carcinoma, Hepatocellular 628Rectal Neoplasms 569Stomach Neoplasms 544Brain Neoplasms 483Ovarian Neoplasms 438Anxiety Disorders 419Pain 418Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 374Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 339Melanoma 322Multiple Myeloma 321Lymphoma 305Depression 305Endometrial Neoplasms 289Liver Neoplasms 279

Interventions

Hearing Tests 1Dexamethasone 1Cisplatin 1Audiometry 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase NA × Ototoxicity × Clear all
NCT06036407 2026-04-14

HEAR

University of Bern

Phase NA Completed
476 enrolled

Ototoxicity, Neoplasms, Hearing Loss

NCT05789316 2026-01-12

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Washington University School of Medicine

Phase NA Completed
55 enrolled
Head & Neck

Ototoxicity, Head and Neck Neoplasms, Hearing Loss

NCT05936034 2025-11-28

PROTOTOX

Institut de Cancérologie de Lorraine

Phase NA Recruiting
52 enrolled

Ototoxicity, Hearing Disorders, Neoplasms

NCT06957132 2025-05-04

RISP-OTOTOX

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Not yet recruiting
500 enrolled

Ototoxicity, Neoplasms

NCT03400709 2018-01-17

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Hospital San Juan de Dios, Santiago

Phase NA Completed
45 enrolled

Ototoxicity

NCT02382068 2017-11-09

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Ohio State University Comprehensive Cancer Center

Phase NA Withdrawn

Ototoxicity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡